FBN1 exon 2 splicing error in a patient with Marfan syndrome

被引:0
作者
Guo, D
Tan, FK
Cantu, A
Plon, SE
Milewicz, DM
机构
[1] Univ Texas, Sch Med, Dept Internal Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2001年 / 101卷 / 02期
关键词
Marfan syndrome; FBN1; fibrillin-1; microfibril;
D O I
10.1002/1096-8628(20010615)101:2<130::AID-AJMG1333>3.0.CO;2-V
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mutations in FBN1 cause the autosomal dominant condition, Marfan syndrome. A single-base mutation that results in a skipping of exon 2 of FBN1 was found in a Marfan patient. By sequencing this proband's entire FBN1 gene and comparing the mutated DNA sequence with proband's unaffected family numbers, we confirmed this alteration was the causative mutation. The skipping of exon 2 creates a frameshift and premature termination codon, and forms a truncated fibrillin-1 composed only of 55 amino acids of N-terminus plus 45 nonsense amino acids. The mRNA transcription levels of the mutated FBN1 allele and the deposition of fibrillin-1 into extracellular matrix in fibroblast cells culture were assessed. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:130 / 134
页数:5
相关论文
共 23 条
[1]   QUANTITATIVE DIFFERENCES IN BIOSYNTHESIS AND EXTRACELLULAR DEPOSITION OF FIBRILLIN IN CULTURED FIBROBLASTS DISTINGUISH 5 GROUPS OF MARFAN-SYNDROME PATIENTS AND SUGGEST DISTINCT PATHOGENETIC MECHANISMS [J].
AOYAMA, T ;
FRANCKE, U ;
DIETZ, HC ;
FURTHMAYR, H .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :130-137
[2]  
DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO
[3]  
2-R
[4]  
Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504
[5]   MARFAN PHENOTYPE VARIABILITY IN A FAMILY SEGREGATING A MISSENSE MUTATION IN THE EPIDERMAL GROWTH-FACTOR LIKE MOTIF OF THE FIBRILLIN GENE [J].
DIETZ, HC ;
PYERITZ, RE ;
PUFFENBERGER, EG ;
KENDZIOR, RJ ;
CORSON, GM ;
MASLEN, CL ;
SAKAI, LY ;
FRANCOMANO, CA ;
CUTTING, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1674-1680
[6]   4 NOVEL FBN1 MUTATIONS - SIGNIFICANCE FOR MUTANT TRANSCRIPT LEVEL AND EGF-LIKE DOMAIN CALCIUM-BINDING IN THE PATHOGENESIS OF MARFAN-SYNDROME [J].
DIETZ, HC ;
MCINTOSH, I ;
SAKAI, LY ;
CORSON, GM ;
CHALBERG, SC ;
PYERITZ, RE ;
FRANCOMANO, CA .
GENOMICS, 1993, 17 (02) :468-475
[7]   MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE [J].
DIETZ, HC ;
CUTTING, GR ;
PYERITZ, RE ;
MASLEN, CL ;
SAKAI, LY ;
CORSON, GM ;
PUFFENBERGER, EG ;
HAMOSH, A ;
NANTHAKUMAR, EJ ;
CURRISTIN, SM ;
STETTEN, G ;
MEYERS, DA ;
FRANCOMANO, CA .
NATURE, 1991, 352 (6333) :337-339
[8]   EXPRESSION OF A MUTANT HUMAN FIBRILLIN ALLELE UPON A NORMAL HUMAN OR MURINE GENETIC BACKGROUND RECAPITULATES A MARFAN CELLULAR PHENOTYPE [J].
ELDADAH, ZA ;
BRENN, T ;
FURTHMAYR, H ;
DIETZ, HC .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :874-880
[9]   MARFAN-SYNDROME - LONG-TERM SURVIVAL AND COMPLICATIONS AFTER AORTIC-ANEURYSM REPAIR [J].
FINKBOHNER, R ;
JOHNSTON, D ;
CRAWFORD, ES ;
COSELLI, J ;
MILEWICZ, DM .
CIRCULATION, 1995, 91 (03) :728-733
[10]  
GLANVILLE RW, 1994, J BIOL CHEM, V269, P26630